India, with its vast population and diverse geographical features, presents a significant challenge in the management and control of vector-borne diseases. This review aims to provide a comprehensive understanding of the burden of such diseases in India, focusing on their epidemiology, clinical manifestations, and control strategies.
Vector-borne diseases, including malaria, dengue, chikungunya, Japanese encephalitis, and lymphatic filariasis, are a major public health concern in India. The country accounts for 4% of the global burden of these diseases, with the highest prevalence observed in the eastern and northeastern regions. The epidemiological profile of these diseases is influenced by factors such as climate, vector behavior, and socioeconomic conditions.
The clinical manifestations of vector-borne diseases are diverse, often leading to diagnostic challenges. Malaria presents with fever, chills, and anemia; dengue with high fever, severe headache, and joint pain; chikungunya with fever and severe joint pain; Japanese encephalitis with fever, headache, and mental status changes; and lymphatic filariasis with lymphedema and elephantiasis. Timely diagnosis is crucial to prevent complications and reduce mortality.
Control strategies for vector-borne diseases in India involve vector control, early diagnosis, prompt treatment, and community education. Vector control includes environmental management and use of insecticides. Early diagnosis and prompt treatment are achieved through strengthening health systems and surveillance. Community education is essential to raise awareness about prevention measures.
Vector-borne diseases pose a significant health burden in India. Understanding their epidemiology, clinical manifestations, and control strategies is essential for healthcare professionals. Collaborative efforts between the government, healthcare providers, and communities can help mitigate the impact of these diseases.
1.
For the treatment of vestibular schwannomas in neurofibromatosis type 2, stereotactic radiosurgery has been found to be effective.
2.
FDA Advisors Recommend Galleri Multicancer Blood Test
3.
Women who miss their first mammogram face higher risk of breast cancer death, study finds
4.
Thriving while surviving: Understanding the social needs of cancer survivors
5.
Can Accelerated Salvage RT Improve Prostate Cancer Control?
1.
Fatigue and Work Participation in Blood Disease: A Comprehensive Review
2.
First-Line Immuno-Hematology Examinations: Essential Diagnostic Tools for Patient Care
3.
The benefits and risks of taking fludrocortisone for adrenal insufficiency
4.
The Algorithmic Revolution: How AI is Reshaping Precision Oncology from Bench to Bedside
5.
Childhood Cancer Prevention Through Modifiable Exposure Reduction
1.
International Conference on Oncology, Cancer Prevention and Public Health
2.
International Conference on Cancer Nursing and Rehabilitation Strategies
3.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
4.
International Conference on Innovations in Critical Care for Oncology and Cardiology
5.
International Symposium on Oncology, Cardiology and Critical Care Innovations
1.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VI
2.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part III
3.
Understanding Common Causes of Abnormal Blood Counts
4.
Hematologic Fatigue and Work Function: Clinical Implications, Pathophysiology, and Management
5.
Treatment Paradigm for Patients with R/R Adult B-cell ALL- Expert Discussions
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation